<DOC>
	<DOCNO>NCT00947245</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics follow single oral multiple oral dos BMS-791325 healthy Japanese subject .</brief_summary>
	<brief_title>Japanese Bridging Study Conducted United States</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Healthy male female subject age 20 49 year , BMI 1830 kg/m2 First generation Japanese . Subject born Japan live outside Japan &gt; 10 year , subject trace maternal paternal Japanese ancestry Any significant acute chronic medical illness . Women pregnant , breastfeeding , unwilling unable use acceptable method birth control . Gastrointestinal disease may impact absorption study drug require treatment protocon inhibitor , antacid H2 blocker . History eczema , psoriasis , intermittent active dermatitis . Positive HIV HCV</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>